• 
  MBC Every1, E Channel’s ‘Dolsing N Mosol’ draws scrutiny ahead of premiere MBC Every1 and E Channel’s new variety show “Dolsing N Mosol” on Monday released viewing points ahead of its first broadcast. The program follows divorced women who want to love again and men who have never dated as they meet at a “dating dorm school” and learn about relationships. Producers have promoted it as an unprecedented pairing, highlighting raw emotions and unpredictable developments. The premise brings together people at sharply different stages: those who have experienced mar April 14, 2026
• 
  StreamMusic Launches Web-Based Service to Settle and Manage Overseas Royalties for K-pop Rights Holders StreamMusic, a tenant company at the Korea Creative Content Agency’s CKL Corporate Support Center, has launched an “overseas royalty settlement and management service” for K-pop copyright holders, aiming to address growing challenges in managing rights as the global music market expands. The company said the service is designed to manage overseas royalty income more systematically and transparently. As K-pop has spread globally, royalties have been generated through overseas streaming, co April 14, 2026
• 
  Korean Internet Banks Lift Deposit Rates Into 3% Range to Compete for Savers As major commercial banks keep deposit rates in the 2% range, South Korea’s internet-only banks are competing for funding by offering rates even 0.1 percentage point higher. The strategy is aimed at attracting rate-sensitive savers seeking higher returns on deposits. According to the financial sector on Monday, key deposit and savings products at internet banks are generally priced in the 3% range. KakaoBank raised rates on some funding products by up to 0.1 percentage point starting Mon April 14, 2026
• 
  Ildong Pharmaceutical Expands DropTop Cholesterol Drug Supply to Three More ASEAN Countries Ildong Pharmaceutical said April 14 it signed an additional agreement with its Indonesian partner, Kalbe Pharma, to expand the supply territory for its drug DropTop as it broadens its presence in Southeast Asia. DropTop is a combination therapy for dyslipidemia that pairs rosuvastatin, a statin that inhibits cholesterol synthesis, with ezetimibe, which reduces cholesterol absorption. Ildong said it signed a contract with Kalbe International, a distribution affiliate of Kalbe Pharma, to e April 14, 2026
• 
  How Director Lee Sang-min and Actor Kim Hye-yoon Built the Fear in 'Salmokji' A film is made through many points of view. Even in the same place at the same time, a director and actors may experience the moment differently. “Choi Song-hee’s B-Cut” looks beyond the “A-cut” on screen to the vivid record of what happened on set. By weaving interviews with directors and actors, it reconstructs the “B-cut” moments that were often more intense than the finished frame. <Editor’s note> NOTE: This story contains spoilers for the film. The horror film “Salmokji” begi April 14, 2026
• 
  KB Kookmin Bank Launches New KOSPI 200-Linked Deposit With Up to 13.8% Annual Return KB Kookmin Bank said April 14 it has launched the “KB Star Equity-Linked Deposit (ELD) 26-3,” a principal-protected product if held to maturity that can offer additional returns depending on the performance of the underlying asset. The one-year product is linked to the KOSPI 200 index and comes in three structures: an upside participation type (minimum-rate guaranteed), an upside knock-out type (minimum-rate guaranteed), and an upside knock-out type (high-yield seeking). For the upside p April 14, 2026
• 
  Celltrion Completes Cancellation of 9.11 Million Treasury Shares, Industry’s Largest Celltrion said Tuesday that its largest-ever cancellation of treasury shares has been fully reflected in the stock market following a change listing on April 13. With the process complete, the company said its total number of outstanding shares fell by about 4%. Celltrion described the move as the largest treasury-share cancellation ever in South Korea’s pharmaceutical and biotech industry. The canceled shares accounted for about 74% of the company’s treasury stock and 3.94% of total iss April 14, 2026
• 
  Huons Biopharma Names Lee Jeong-hee as New CEO Huons Biopharma, a Huons Group company specializing in botulinum toxin, said April 14 it has appointed Lee Jeong-hee, an executive director, as its new CEO. Lee, born in 1976, earned an MBA from Aalto University in Finland. He has more than 23 years of experience in the dermatology and medical aesthetics market, working in marketing, sales and strategic planning at Ipsen Korea, Hanwha Pharma, Hugel, Daewoong Pharmaceutical, Jetema and Chong Kun Dang Bio, among others. The company said April 14, 2026
• 
  Korea’s Traditional Soban Tables Get Modern Showcase at Milan Design Week Korea’s traditional soban, a small low table, will be presented in new forms at Milan Design Week, one of the world’s largest design events. The Seoul Design Foundation said Monday it will stage an international exhibition, “Seoul Life 2026 Milan: Heritage Reimagined, Soban,” from April 20 to May 10 at Italy’s ADI Design Museum. The project is hosted and organized by the Seoul Metropolitan Government and the Seoul Design Foundation, with cooperation from the ADI Design Museum. It aims to April 14, 2026
• 
  KB Kookmin Bank Tightens Oversight of Loan Process to Strengthen Consumer Protection KB Kookmin Bank said on the 14th it will strengthen internal management standards across the entire loan process to bolster financial consumer protection. The measures include monitoring using the Consumer Protection Quality Index (CPQI), tighter management of loans to vulnerable groups, and an overhaul of a pre-review checklist for consumer protection. Within this month, the bank will add key credit indicators to CPQI — including the status of new loans to older customers and first-time April 14, 2026